Medical News

RSS

CARE invests $1.8 billion to reduce maternal mortality by 2015

Today the humanitarian organization CARE announced that it will invest $1.8 billion to expand its maternal, newborn and child health programs to more than 30 countries in five years. This investment will deepen CARE's commitment to the United Nations Millennium Development Goals (MDGs) aimed at reducing child and maternal mortality by 2015 and will support the United Nations Secretary General's Global Strategy on Women's and Children's Health, which will be unveiled at next week's MDG Summit.

17 Sep 2010

Shrink Nanotechnologies files patent for CellAlign tissue engineering technology

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that certain patent applications related to its advanced tissue engineering technology platform, CellAlign, have been filed.

17 Sep 2010

Transcatheter Technologies implants transapical aortic valve in acute porcine model

Transcatheter Technologies GmbH (TT), an innovative medical device company that is developing a second-generation transcatheter aortic valve prosthesis, announced today that its proprietary transapical aortic valve has been successfully implanted in the acute porcine model.

17 Sep 2010

Researchers load biological molecules onto 'nanosprings'

Researchers at Oregon State University have reported the successful loading of biological molecules onto "nanosprings" - a type of nanostructure that has gained significant interest in recent years for its ability to maximize surface area in microreactors.

17 Sep 2010

BioSpace and BioMed Central launch Career Network

BioSpace and BioMed Central are announcing the launch of the BioMed Central Career Network today, a new online community for life science professionals seeking quality recruitment, job opportunities and industry news.

17 Sep 2010

Scott & White Healthcare recruits patients for Phase III lung cancer trial

Scott & White Healthcare in Round Rock, Texas is recruiting patients for a Phase III lung cancer trial aimed at preventing the disease's recurrence in previously treated patients. The trial will evaluate the potential of an immunotherapy called Antigen-Specific Cancer Immunotherapeutic (ASCI) for the treatment of Non-Small Cell Lung Cancer (NSCLC).

17 Sep 2010

St. Joseph's Hospital-North adds obstetric services

Moms-to-be have asked for it and now St. Joseph's Hospital-North delivers a birthing experience like no other hospital stay. The area's first new hospital in more than 30 years has added obstetric services, bringing new moms and babies comfortable care in a soothing, elegant environment.

17 Sep 2010

HearPO and American Diabetes Association enter National Strategic Partnership

HearPO is proud to announce a National Strategic Partnership with the American Diabetes Association. This National Strategic Partnership will provide additional resources and avenues to educate people with diabetes, medical practitioners and the general public about the connection between diabetes and hearing loss.

17 Sep 2010

Illicit drug usage increases among Americans: SAMHSA survey

The use of illicit drugs among Americans increased between 2008 and 2009 according to a national survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA). The National Survey on Drug Use and Health (NSDUH) shows the overall rate of current illicit drug use in the United States rose from 8.0 percent of the population aged 12 and older in 2008 to 8.7 percent in 2009. This rise in overall drug use was driven in large part by increases in marijuana use.

17 Sep 2010

Simian immunodeficiency virus is at least 32,000 to 75,000 years old

An ancestor of HIV that infects monkeys is thousands of years older than previously thought, suggesting that HIV, which causes AIDS, is not likely to stop killing humans anytime soon, finds a study by University of Arizona and Tulane University researchers.

17 Sep 2010

Cornea and Laser Eye Institute to study CXL effectiveness in keratoconus patients

The Cornea and Laser Eye Institute, with Principal Investigator, Peter S. Hersh M.D., is conducting a research study to study the safety and effectiveness of corneal collagen crosslinking (CXL) using Riboflavin/Dextran and Hypotonic Riboflavin in patients with progressive keratoconus and corneal ectasia.

17 Sep 2010

Media reporting can reduce impact of infectious disease outbreaks

At the first sign of a disease pandemic, public health officials should begin strongly communicating about the extent of the outbreak and the steps that can be taken by the public to avoid infection. That's the recommendation of two mathematical biologists who have modified the most widely used infectious disease transmission model to account for the impact of news media coverage.

17 Sep 2010

Research on signaling pathways may help to design therapy for neurodevelopmental disorders

Researchers at the Center for Neuroscience Research at Children's National Medical Center have discovered that the two major types of signaling pathways activated during brain cell development-the epidermal growth factor receptor pathway and the Notch pathway-operate together to determine how many and which types of brain cells are created during growth and repair in developing and adult brains.

17 Sep 2010

Healthier people select high-deductible health plans

Healthier people are more likely to select a high-deductible health plan over a conventional plan, according to data from several employers that first offered the option in 2006. Participants choosing one of the new plans were eligible for contributions to a tax-free health savings account (HSA).

17 Sep 2010

Elite Pharmaceuticals signs agreements with Precision Dose for four generic products

Elite Pharmaceuticals, Inc. announced today the signing of a license agreement and a manufacturing and supply agreement with Precision Dose, Inc. which has a wholly owned subsidiary, TAGI Pharma, Inc. which will distribute the products covered by the agreement. Pursuant to the License Agreement, TAGI Pharma will market and sell four Elite generic products in the United States, Puerto Rico and Canada.

17 Sep 2010

New Census Bureau figures indicate record number of Americans among the ranks of the uninsured

According to a Census Bureau announcement this morning, the number of people without health insurance coverage increased from 46.3 million in 2008 to 50.7 million in 2009. Read the Census Bureau's summary of key findings or gain access to the full report here.

17 Sep 2010

Johnson & Johnson, Crucell announce advanced negotiations for potential public offer

Johnson & Johnson and Crucell N.V. today announced that they are in advanced negotiations for a potential public offer by Johnson & Johnson or an affiliate for all outstanding ordinary shares of Crucell not already held by Johnson & Johnson and its affiliates.

17 Sep 2010

Pharma Lynx licenses NewCardio's QTinno automated cardiac safety solution

NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that Pharma Lynx, a global contract research organization and a subsidiary of Diverse Lynx, has signed an MSA to license NewCardio's QTinno™ solution for use in Phase 1 studies. Pharma Lynx has particular expertise in oncology studies, including QTc studies involving both healthy subjects and cancer patients, and QTinno will add to Pharma Lynx's already robust capabilities, enabling it to deliver fully automated QTc studies to its sponsors.

17 Sep 2010

WHO urges development programs to include mental and psychosocial disabled patients

People with mental and psychosocial disabilities are among the most marginalized groups in developing countries. Even though development actors have pledged to focus their work on the most vulnerable in a community, many programmes continue to ignore and exclude this vulnerable group.

17 Sep 2010

BCM-95 curcumin exhibits anti-inflammatory properties

Top researchers at the Gastrointestinal Cancer Research Lab at Baylor University Medical Center in Dallas are exploring the clinical applications of BCM-95®, a new patented extract of curcumin with unprecedented potency, and bioavailability.

17 Sep 2010

Medical News

CARE invests $1.8 billion to reduce maternal mortality by 2015

Shrink Nanotechnologies files patent for CellAlign tissue engineering technology

Transcatheter Technologies implants transapical aortic valve in acute porcine model

Researchers load biological molecules onto 'nanosprings'

BioSpace and BioMed Central launch Career Network

Scott & White Healthcare recruits patients for Phase III lung cancer trial

St. Joseph's Hospital-North adds obstetric services

HearPO and American Diabetes Association enter National Strategic Partnership

Illicit drug usage increases among Americans: SAMHSA survey

Simian immunodeficiency virus is at least 32,000 to 75,000 years old

Cornea and Laser Eye Institute to study CXL effectiveness in keratoconus patients

Media reporting can reduce impact of infectious disease outbreaks

Research on signaling pathways may help to design therapy for neurodevelopmental disorders

Healthier people select high-deductible health plans

Elite Pharmaceuticals signs agreements with Precision Dose for four generic products

New Census Bureau figures indicate record number of Americans among the ranks of the uninsured

Johnson & Johnson, Crucell announce advanced negotiations for potential public offer

Pharma Lynx licenses NewCardio's QTinno automated cardiac safety solution

WHO urges development programs to include mental and psychosocial disabled patients

BCM-95 curcumin exhibits anti-inflammatory properties

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News